CellaVision (Sweden) Insiders
| CEVI Stock | SEK 218.50 5.50 2.46% |
CellaVision employs about 235 people. The company is managed by 8 executives with a total tenure of roughly 9 years, averaging almost 1.0 years of service per executive, having 29.38 employees per reported executive. Breaking down CellaVision's management performance can provide insight into the firm performance.
| Peter Wilson President Vice President Global Marketing |
CellaVision |
CellaVision Management Team Effectiveness
The company has return on total asset (ROA) of 0.1152 % which means that it generated a profit of $0.1152 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1997 %, meaning that it generated $0.1997 on every $100 dollars invested by stockholders. CellaVision's management efficiency ratios could be used to measure how well CellaVision manages its routine affairs as well as how well it operates its assets and liabilities.CellaVision Workforce Comparison
CellaVision AB is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 566. CellaVision totals roughly 235 in number of employees claiming about 42% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.19 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25. CellaVision AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. CellaVision AB Price Series Summation is a cross summation of CellaVision price series and its benchmark/peer.
CellaVision Notable Stakeholders
A CellaVision stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CellaVision often face trade-offs trying to please all of them. CellaVision's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CellaVision's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Peter Wilson | Vice President Global Marketing | Profile | |
| Yve Thorenburg | Acting Sales | Profile | |
| Julien Veyssy | Managing Diagnostics | Profile | |
| Magnus Blixt | Ex Officer | Profile | |
| Urban Strindlov | VP Sales | Profile | |
| Maths hc | Founder Director | Profile | |
| Simon Ostergaard | CEO Pres | Profile | |
| Nina Wallander | VP HR | Profile |
About CellaVision Management Performance
The success or failure of an entity such as CellaVision AB often depends on how effective the management is. CellaVision management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CellaVision management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CellaVision management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
CellaVision AB develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden and internationally. CellaVision AB was founded in 1994 and is headquartered in Lund, Sweden. CellaVision operates under High Precision And Instrumentation Products classification in Sweden and is traded on Stockholm Stock Exchange. It employs 129 people.
Please note, the imprecision that can be found in CellaVision's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CellaVision AB. Check CellaVision's Beneish M Score to see the likelihood of CellaVision's management manipulating its earnings.
CellaVision Workforce Analysis
Traditionally, organizations such as CellaVision use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CellaVision within its industry.CellaVision Manpower Efficiency
Return on CellaVision Manpower
| Revenue Per Employee | 2.4M | |
| Revenue Per Executive | 70.7M | |
| Net Income Per Employee | 673.6K | |
| Net Income Per Executive | 19.8M | |
| Working Capital Per Employee | 659.6K | |
| Working Capital Per Executive | 19.4M |
Additional Tools for CellaVision Stock Analysis
When running CellaVision's price analysis, check to measure CellaVision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CellaVision is operating at the current time. Most of CellaVision's value examination focuses on studying past and present price action to predict the probability of CellaVision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CellaVision's price. Additionally, you may evaluate how the addition of CellaVision to your portfolios can decrease your overall portfolio volatility.